Flu Vaccines NIP

A colourful, cartoon‑friendly guide to 2025 NIP influenza vaccines in Australia.
Based on your uploaded 2025 NIP influenza advice. Educational only — always follow local policy and clinical judgement.

Personalise

Highlights when NIP‑funded cohorts apply
Yes
Yes
Yes
Yes
Yes
Tip: toggle what applies to you — matching vaccine cards will glow.

Vaccines

Egg‑based QIVs
FluQuadri® / Vaxigrip Tetra®
NIP funded — cohort‑based
What to know
  • QIV only in 2025 (4 strains).
  • Funding: NIP for all children 6 months to <5 years, plus First Nations, pregnancy, and eligible medical conditions. Others are private (5–64).
  • Dosing first year 6m–<9y: 2 doses ≥4 weeks apart; then 1 dose annually.
  • Co‑admin: With COVID‑19; in pregnancy may be co‑given with pertussis (20–32 wks) and maternal RSV (28–36 wks).
  • Egg allergy: Not a contraindication. Latex: NIP 2025 flu vaccines are latex‑free.
Cell‑based QIV
Flucelvax® Quad
NIP funded — 5–64 at higher risk
What to know
  • Funding: Ages 5–64 with eligible medical conditions.
  • Preference: No preference vs standard egg‑based QIVs.
  • Co‑admin: Can be given with COVID‑19 vaccines.
Adjuvanted QIV (65+)
Fluad® Quad
NIP funded — 65 years and over
What to know
  • Preferentially recommended over standard QIVs for adults ≥65 years.
  • Co‑admin: Can be given with COVID‑19 and shingles vaccines.
Who gets a free NIP flu vaccine?
Eligibility quick guide
See funded groups
  • Children 6 months to <5 years.
  • Pregnant women — any stage, every pregnancy.
  • Aboriginal and Torres Strait Islander people aged ≥6 months.
  • People aged ≥65 years (adjuvanted QIV recommended).
  • People aged ≥6 months with certain medical conditions (e.g., chronic cardiac, respiratory incl. severe asthma, immunocompromise, haematological, metabolic incl. diabetes, chronic kidney, neurological conditions; long‑term aspirin in children 5–10).

Start when vaccine is available (Mar/Apr 2025) and continue while influenza circulates.

NIP funding by age group (summary)

Age group FluQuadri® Vaxigrip Tetra® Flucelvax® Quad Fluad® Quad
6 months – <5 years✔︎ NIP funded✔︎ NIP funded
5 – <60 years* Funded for First Nations / pregnancy / eligible conditions* Funded for First Nations / pregnancy / eligible conditions* Funded for eligible conditions (5–64)
60 – <65 years* Funded for cohorts above* Funded for cohorts above* Funded for eligible conditions
≥65 years✔︎ NIP funded (preferential)

Asterisks (*) indicate funding only for specified cohorts. Other private market options may exist.

Developer tests (click to expand)